MedPath
FDA Approval

NEOPROFEN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 2, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ibuprofen(10 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alcami Carolinas Corporation

Recordati Rare Diseases Inc.

832394733

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NEOPROFEN

Product Details

NDC Product Code
55292-122
Application Number
NDA021903
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
October 31, 2023
IbuprofenActive
Code: N01ORX9D6SClass: ACTIMQuantity: 10 mg in 1 mL
waterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath